Cash And Equivalent Endring Dato
AbbVie USD 18.07B 4.78B 2024-03
Alnylam Pharmaceuticals USD 681.88M 130.81M 2024-03
Amarin USD 213.94M 14.69M 2024-03
AstraZeneca USD 7.84B 2B 2024-03
DBV Technologies USD 101.52M 29.31M 2024-03
GlaxoSmithKline GBP 2.79B 146M 2024-03
Halozyme Therapeutics USD 164.63M 46.26M 2024-03
Ionis Pharmaceuticals USD 348.89M 50.38M 2024-03
Neurocrine Biosciences USD 396.3M 102.6M 2024-03
Novartis USD 9.47B 3.92B 2024-03



Amarin Kontanter Og Tilsvarende - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.